News of New York

Eli Lilly’s Tirzepatide Reduces Heart Failure Risks, Study Reveals
1 August 2024
3142
Revolutionary Heart Failure Treatment Eli Lilly’s drug tirzepatide, marketed as Mounjaro for diabetes and Zepbound for weight loss, has shown promising results in improving symptoms in heart failure patients with obesity, the co...
Pfizer has applied to the US for approval of its COVID-19 vaccine for children under five
2 February 2022
3756
Vaccine for children Pfizer and BioNTech have urged US authorities to approve a coronavirus vaccine for children aged 6 months to 5 years, according to a statement published on Pfizer's website on Tuesday. Pfizer's Albert Bourla said...
Index futures are declining: Johnson & Johnson beats Wall Street expectations
25 January 2022
3402
Stock indices on Tuesday US stock indices will open lower, which could be another volatile session for investors after Monday's strong swings. Nasdaq Composite futures are down 2%, while S&P 500 and Dow Jones futures are down about 0.7%. On Tue...
Albert Bourla supports the idea of primary vaccination against coronavirus on a three-dose basis
17 January 2022
3968
Vaccination against COVID Albert Bourla, CEO of the US pharmaceutical company Pfizer, believes it is necessary to vaccinate people with three doses of the coronavirus vaccine to fight the pandemic&nb...
Pfizer and Moderna get FDA approval for their COVID-19 booster vaccines
22 November 2021
4018
Booster vaccines The FDA and CDC in the US on Friday approved Pfizer (PFE)/BioNTech (BNTX) and Moderna (MRNA) booster vaccines against COVID-19 for all adults in the US. Revaccination with J&...
Pfizer gets $5.29bn government contract to supply US with Covid-19 pills
19 November 2021
4340
Government contract for Pfizer Shares in Pfizer (PFE) have risen amid reports that the US government has ordered 10 million courses of treatment with its Pfizer Paxlovid tablets for COVID-19. President Joe Biden said o...
Pfizer shares up 11%
8 November 2021
3722
The COVID pill Shares of Pfizer (PFE) jumped sharply Friday, following the release of stronger efficacy results for its COVID-19 pill compared to its Merck (MRK) counterpart. Shares of other coronavirus drug makers as well as vaccine makers fell. He...
Johnson & Johnson reports $502m sales of Covid vaccine in third quarter report
19 October 2021
3758
Vaccine sales J&J Company (JNJ) reported its financial results for the third quarter of 2021 earnings per share exceeded market analysts' forecasts, but revenues fell short of estimates. Sales of COVID-19 vaccines t...
Stocks rise on boom in Goldman Sachs profits
15 October 2021
4174
Friday trading US stock indices rallied on Friday as investors absorbed Goldman Sachs' sharp gain and an unexpected rise in retail sales. The Dow Jones Industrial Average jumped 207 points, or 0.59%, while the S&P 500 and Nasdaq Composite indice...
Stocks rise as oil hits 7-year high
5 October 2021
3697
Stocks rise US stock indices rose on Tuesday as the major averages are expected to stabilise at or near their lowest level in months. The Dow Jones Industrial Average rose 114 points, or 0.34 pe...
Palantir shares up 9%
13 August 2021
4004
Share price, earnings and forecasts Data analytics company Palantir (PLTR) has released its second-quarter financial report, which pleased investors. Palantir's customer base is growing, allowing the company to scale. Palantir (PLTR) shares, up 18....
AstraZeneca will continue to seek certification for its vaccine in the United States
29 July 2021
3822
Vaccine certification British-Swedish pharmaceutical company AstraZeneca will continue to push for certification of its vaccine by the US Food and Drug Administration (FDA). The company's chief executive, Pascal Soriot,...
U.S. purchases another 200 million doses of coronavirus vaccine from Pfizer
24 July 2021
6422
COVID-19 vaccine The US administration has purchased a further 200 million doses of coronavirus vaccine from a US company and its German partner BioNTech. This was confirmed by White House press secretary Jennifer ...
Novavax applies for FDA approval of its COVID-19 vaccine
15 June 2021
4043
Vaccine approval application Novavax will be another major international supplier of vaccines against COVID-19, as trials of its NVX-CoV2373 vaccine have shown an overall effectiveness of 90.4% with good tolerability. Novavax expects coronaviru...
Vir Biotechnology is ready to present a new drug for COVID-19
12 March 2021
3955
New drug from COVID-19 Vir Biotechnology (NASDAQ:VIR) shares jumped more than 30% in trading in New York. Shares rose after the company said its experimental treatment COVID-19, being deve...
Johnson & Johnson's COVID -19 vaccine receives FDA approval
1 March 2021
3378
FDA approves vaccine Johnson&Johnson has received approval for emergency use of its vaccine in the US, with the advantages of single-dose administration and standard storage requirements. Johnson&Johnson receiv...
American stock indices rose 0.3-0.6%
8 February 2021
3897
Rising value of indices The US stock market surged in trading on Friday, with the S&P 500 and Nasdaq indices reaching record highs. By the end of last week Dow Jones indicator rose by 3.9%, the highest since the week ended November 13, notes Mar...
Palantir shares increased by 20%
9 December 2020
3591
Three year contract Palantir has signed a three-year contract with the US Food and Drug Administration (FDA) to provide its software for the integration and analysis of data during drug testing. Palantir Technologies (PLTR) shares, which have incre...
Tesla and Uber fell at the pre-market
9 December 2020
3340
New York Stock Exchange Uber shares fell 1.5 per cent in the NYSE pre-market after a taxi company said plans to sell its unmanned car manufacturing subsidiary to Aurora Technologies. It is selling a division that was once considered critical to the ...
United Airlines delivers the vaccine worldwide
29 November 2020
3161
Delivery of vaccine United Airlines (UAIR) has launched charter flights in which the company delivers COVID-19 vaccine to special warehouses located around the world. This is in order to ensure that ...
  • 1
  • 2
Companies rating
Instagram
35 Mention
Netflix
22 Mention
Us Weekly
17 Mention

NEW YORK NEWS

News from GlobalNY.biz is the freshest and most relevant information about high-profile events in the region. The task of the resource's news feed is to convey to readers with maximum accuracy and objectivity information about important events in business, politics, economy, healthcare, culture and other spheres of life in New York.
GlobalNY.biz news is a coverage of economic processes taking place in New York, the latest news of public life, incidents and an overview of political events. New York news is information about the activities of small and medium-sized businesses, the work of housing and communal services and utilities, the implementation of significant projects.
The site's journalists describe not only the life of the region, but also talk about the current state of the US economy. Everything you need to know about innovations in the field of industry and agriculture, economy and power is collected in the "News" section at GlobalNY.biz.
New York news quickly informs the reader, shows the real picture and opens up hot topics. Communication with government structures and business enables us to provide our readers with reliable, information-rich material. The main page of the portal contains the key news of New York!
Alena Potapova

Development Director
Population
8,204,093,999
Died this year
17,335,105
Born this year
42,647,425